Parviz Ghahramani

Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule

José Baselga, Xavier Carbonell, Noel-Jaime Castañeda-Soto et al. · Journal of Clinical Oncology · 2005 · 426 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens

Lynn Purkins, Nolan Wood, Parviz Ghahramani et al. · Antimicrobial Agents and Chemotherapy · 2002 · 413 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13

Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer

U. Gatzemeier, G. Groth, Charles Butts et al. · Annals of Oncology · 2003 · 384 citations · Full text

Medicine, Oncology, Pharmacology +15

Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel

Brian Leyland‐Jones, Karen A. Gelmon, Jean-Pierre Ayoub et al. · Journal of Clinical Oncology · 2003 · 296 citations

Medicine, Oncology, Pharmacology +17

Translational Medicine definition by the European Society for Translational Medicine

Randall J. Cohrs, Tyler Martin, Parviz Ghahramani et al. · European Journal of Molecular & Clinical Medicine · 2014 · 172 citations · Full text

Pharmacy, Biomedical Sciences, Translational Sciences +9